EBOS delivers record profit

However total Australian revenue declined, driven by a $333m reduction in hepatitis C medicine sales Leading wholesaler, pharmacy and animal care company EBOS Group has announced a net profit after tax of $AU137million ($NZ149.6million) for the 2018 financial year, up 12.2%. In its community pharmacy business, EBOS saw moderate revenue growth (excluding hepatitis C medicines